The ticket master is sick. Can blockchain be medicine?


Welcome to TechCrunch Exchange, the weekly startups and markets newsletter. It’s inspired by the daily TechCrunch+ column from which it got its name. Want it in your inbox every Saturday? Register here.

When the cure is done When frontman Robert Smith said he was “sick” of Ticketmaster’s fees, many of us felt vindicated. The platform then issued some refunds, but skulls are now on it, and they sell full Ticketmaster accounts instead of tickets. Is there still hope for concertgoers? – Anna

Playing Monopoly

If you’re looking for a Ticketmaster alternative, you’re not alone. Whether you’re a fan of Taylor Swift, The Cure or Bad Bunny, there are plenty of reasons to be drawn to the self-described “world’s leading live entertainment ticketing platform.”

Is all hate warranted? Probably not. Or rather, the platform may be carrying more than its share of responsibility. In the year “It’s easy to blame Ticketmaster and say it’s their fault,” former CEO Fred Rosen, who ran the company from 1982 to 1998, told CBC Radio in January. “Desire is what determines price.”

Regulators in many countries beg to disagree. Earlier this year, the US Senate questioned Live Nation, which it acquired Ticketmaster in 2010, over concerns that it was a monopoly.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

18 − 8 =